Literature DB >> 6108541

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.

J S Kim, H H Kornhuber, W Schmid-Burgk, B Holzmüller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108541     DOI: 10.1016/0304-3940(80)90178-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


× No keyword cloud information.
  124 in total

1.  Psychotic disorder after lamotrigine.

Authors:  G M Polselli; E M Pennisi; L Figà Talamanca; R Roberti; F F Garelli; P L Bandinelli
Journal:  Ital J Neurol Sci       Date:  1998-04

Review 2.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

3.  Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.

Authors:  D C Hoffman
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.

Authors:  Nurith Amitai; Athina Markou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

Review 5.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

6.  Isolation rearing or methamphetamine traumatisation induce a "dysconnection" of prefrontal efferents in gerbils: implications for schizophrenia.

Authors:  F Bagorda; G Teuchert-Noodt; K Lehmann
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

7.  The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.

Authors:  R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Glutamate in schizophrenics and healthy controls.

Authors:  W F Gattaz; D Gattaz; H Beckmann
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

Review 9.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

10.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.